WebFounder of Aileron Therapeutics, Inc., Huw M. Nash is Chief Operating & Business Officer at Stoke Therapeutics, Inc. In the past Dr. Nash occupied the position of Vice President-Corporate Development of Aileron Therapeutics, Inc. and VP-External Collaborations & Founding Scientist at NeoGenesis Pharmaceuticals, Inc. WebCytokinetics, Inc. (US:CYTK) has 658 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 120,172,571 shares. ... ESIX - SPDR S&P SmallCap 600 ESG ETF This fund is a listed as child fund of State Street Corp and if that institution has ...
Cytokinetics, Inc. ESG Risk Rating - Sustainalytics
WebJul 27, 2024 · CYTOKINETICS Write a review Snapshot Why Join Us 37 Jobs Reviews 146 Salaries 3 Q&A Interviews Photos Questions and Answers about CYTOKINETICS Popular topics Benefits Hiring Process Browse questions (3) Ask a question How long does it take to get hired from start to finish at CYTOKINETICS? What are the steps along the way? … WebMar 23, 2024 · Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 171% by 2025. Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock. ph hemisphere\u0027s
Cytokinetics To Participate In The 22nd Annual Needham Virtual ...
WebMar 27, 2024 · SOUTH SAN FRANCISCO, Calif., March 27, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced the release of its … WebCytokinetics Remote in Tacoma, WA $120,000 - $175,000 a year As a leader in muscle biology and the mechanics of muscle performance, we are developing small molecule drug candidates specifically engineered to impact muscle… Posted 24 days ago · More... Cardiovascular Account Specialist – U.S. Sales, Myrtle Beach, SC Cytokinetics WebJan 7, 2024 · NEW YORK, NY and SOUTH SAN FRANCISCO, CA, January 7, 2024 – Royalty Pharma plc (Nasdaq: RPRX) and Cytokinetics, Incorporated (Nasdaq: CYTK) … phhenotypes